98-14658. Notice of Availability of Funds; Cooperative Agreement for National Hepatitis B Immunization Program with Focus on Asians and Pacific Islanders  

  • [Federal Register Volume 63, Number 106 (Wednesday, June 3, 1998)]
    [Notices]
    [Pages 30231-30233]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-14658]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [Program Announcement 98063]
    
    
     Notice of Availability of Funds; Cooperative Agreement for 
    National Hepatitis B Immunization Program with Focus on Asians and 
    Pacific Islanders
    
    A. Purpose
    
        The Centers for Disease Control and Prevention (CDC) announces the 
    availability of fiscal year FY 1998 funds for a cooperative agreement 
    to support a Hepatitis B Immunization Project with a focus on Asians 
    and Pacific Islanders. The purpose of this cooperative agreement 
    program is to increase hepatitis B vaccination levels among Asian and 
    Pacific Islander (API) children in the United States born between 1983 
    and 1993 from a baseline of 10 percent in 1996 to 90 percent by the 
    close of year 2000, to enhance local demand for hepatitis B vaccination 
    of API children, and to inform and educate vaccination service 
    providers who serve API children. This program addresses the ``Healthy 
    People 2000'' priority area of Immunization, and Infectious Diseases.
    
    B. Eligible Applicants
    
        Applications may be submitted by public and private nonprofit (and 
    for-profit) organizations, and by governments and their agencies; that 
    is, universities, colleges, research institutions, hospitals, other 
    public and private non profit organizations, State and local 
    governments or their bona fide agents, and federally recognized Indian 
    tribal governments, Indian tribes, or Indian tribal organizations.
    
        Note: Public Law 104-65 states that an organization described in 
    section 501(c)(4) of the Internal Revenue Code of 1986 that engages 
    in lobbying activities is not eligible to receive Federal funds 
    constituting an award, grant, cooperative agreement, contract, loan, 
    or any other form.
    
    C. Availability of Funds
    
        Approximately $49,900 is available in FY 1998 to fund one award. It 
    is expected that the award will begin on or about July 31, 1998, and 
    will be made for a 12-month budget period within a project period of up 
    to three years. Funding estimates may change.
    
    [[Page 30232]]
    
        Continuation awards within an approved project period will be made 
    on the basis of satisfactory progress as evidenced by required reports 
    and the availability of funds.
    
    D. Program Requirements
    
        In achieving the purpose of this effort, the recipient will be 
    responsible for the activities listed under Item 1, (Recipient 
    Activities) and CDC will be responsible for the activities listed under 
    Item 2, (CDC Activities).
    
    1. Recipient Activities
    
        The recipient will promote hepatitis B immunization of all API 
    children in the United States through collaborative education and 
    vaccination activities and sharing of information and resources through 
    the member groups, working groups, volunteers, and national, State, and 
    local public and private health care providers. The grantee will:
        a. Recipient should conduct meetings, form working groups, and 
    maintain reports and other records as necessary related to Hepatitis B 
    Immunization activities.
        b. Work with targeted national organizations and State and local 
    coalitions to facilitate API hepatitis B vaccination coverage surveys 
    and implementation of efforts to educate providers and parents about 
    hepatitis B vaccine (HBV), Vaccines for Children (VFC) Program, and the 
    national recommendations to vaccinate all API children with hepatitis B 
    vaccine.
        c. Work with State and local coalitions to identify barriers and 
    solutions to these barriers in the implementation of hepatitis B 
    vaccination of all API children.
        d. Regularly inform all work groups and volunteers and relevant 
    national, State and local groups of recipient related activities around 
    the country with a published vehicle such as a newsletter.
        e. Develop strategies, action plans, and mechanisms to increase 
    public and private collaboration on activities to ensure hepatitis B 
    vaccination of all API children in the U.S., for example, such as 
    establishing a Web page; organizing volunteer groups; organizing fund-
    raising efforts; developing and utilizing mailing lists; working with 
    Asian language school principals; meeting with Asian language media 
    spokespersons; and working through the federal Vaccines for Children 
    (VFC) network to enroll and educate providers of vaccination services 
    to API children in each of the 12 top API states--California, New York, 
    Hawaii, Texas, Illinois, New Jersey, Washington, Florida, Virginia, 
    Maryland, Pennsylvania, and Massachusetts.
        f. Establish working relationships with API health care providers 
    to enhance their interest and participation in the project.
        g. Devise and implement a linkage of a majority of the existing 
    hepatitis B virus transmission prevention resources with a majority of 
    the nation's API community leaders.
    
    2. Centers for Disease Control and Prevention (CDC) Activities
    
        a. As requested, provide assistance to the recipient, with plans or 
    agendas for proposed activities.
        b. Provide technical assistance through telephone calls, 
    correspondence, and site visits in the area of program and agenda 
    development, implementation, and priority setting related to the 
    cooperative agreement.
        c. Provide scientific collaboration for appropriate aspects of the 
    activities, including information on disease impact and vaccination 
    coverage levels.
        d. Provide speakers, when possible, on such topics and impact of 
    HBV infection in API's, national policy and recommendations related to 
    hepatitis B vaccination of API children.
        e. Assist as requested in reporting and validating relevant 
    hepatitis B vaccination information made available through publication 
    in a newsletter and journal articles and otherwise provided to project 
    members, volunteers, Federal, State, and local health agencies, and 
    health care providers.
        f. Provide representatives to attend executive, steering group and 
    work group conference calls and meetings.
    
    E. Application Content
    
        The application must contain the following:
        1. Objectives consistent with the existing purpose of the applicant 
    organization.
        2. Background information on the applicant; evidence of relevant 
    experience in coordinating groups of diverse organizations; evidence of 
    the applicant's organizational capacity and experience in building and 
    maintaining relationships with national organizations, private and 
    public sector non-profit health care organization, professional health 
    associations, volunteer groups, advocacy groups, API organizations, and 
    government entities.
        4. A clear description of the purpose of the applicant organization 
    along with detailed methods and activities which will be undertaken to 
    ensure vaccination of at least 90 percent of all API children in the 
    U.S. with hepatitis B vaccine by the close of year 2000.
        5. A plan to monitor and evaluate activities.
        6. Biographical information on qualified and experienced 
    administrative and professional personnel who will be working in an 
    existing organizational structure to fulfill the terms of the project.
        7. Letters from current API organizations, API community leaders, 
    and State and local public health agencies which indicate the applicant 
    has their support and involvement in conducting the activities of this 
    project and has an established reputation to motivate other 
    organizations.
        8. A detailed budget and narrative budget justification.
    
    Competing Applications
    
        Use the information in the Program Requirements, Other 
    Requirements, and Evaluation Criteria sections to develop the 
    application content. Your application will be evaluated on the criteria 
    listed, so it is important to follow them in laying out your program 
    plan. The narrative should be no more than 30 double-spaced pages, 
    printed on one side, with one inch margins, and unreduced font.
    
    F. Submission and Deadline
    
    Application
    
        Submit the original and two copies of PHS 5161-1 (OMB Number 0937-
    0189) on or before July 6, 1998. Submit the application to: David 
    Elswick, Grants Management Specialist, Grants Management Branch, 
    Procurement and Grants Office, Announcement 98063, Centers for Disease 
    Control and Prevention (CDC), Room 300, 255 East Paces Ferry Road, NE., 
    Mailstop E-13, Atlanta, Georgia 30305-2209.
        If your application does not arrive in time for submission to the 
    independent review group, it will not be considered in the current 
    competition unless you can provide proof that you mailed it on or 
    before the deadline (i.e., receipt from U.S. Postal Service or a 
    commercial carrier; private metered postmarks are not acceptable).
    
    G. Evaluation Criteria
    
        Each application will be evaluated by an independent review group 
    appointed by CDC to the extent it documents the applicant's:
        1. understanding of the existing disease control problem and the 
    importance and feasibility of hepatitis B vaccination of at least 90 
    percent of all API children in the U.S. by the close of year 2000. (10 
    percent)
    
    [[Page 30233]]
    
        2. specific, realistic, measurable, and time-phased objectives 
    which are related to effective activities. (15 percent)
        3. high quality and effective plan for ensuring implementation of 
    State and local successful hepatitis B vaccination efforts in at least 
    the top 12 API states. (20 percent)
        4. established network of national, State or local collaborators 
    and accessibility to an adequate number of member organization 
    representatives. (20 percent)
        5. administrative and support staff to operate the project. (10 
    percent)
        6. qualified and experienced professional personnel who are 
    committed to the project and will implement the proposed program 
    activities. (10 percent)
        7. appropriate and effective plan to measure activities and 
    evaluate its progress toward the year 2000 goal. (15 percent)
        In addition, consideration will be given to the extent to which the 
    budget request is clearly justified and consistent with the intended 
    use of cooperative agreement funds.
    
    H. Other Requirements
    
    Technical Reporting Requirements
    
        A. Provide CDC with original plus two copies of:
        1. quarterly progress reports describing the progress toward 
    achieving objectives, implementing vaccination programs, and providing 
    services;
        2. financial status report, no more than 90 days after the end of 
    the budget period; and
        3. final financial and performance reports, no more than 90 days 
    after the end of the project period.
        B. Provide an annual report to the project members, summarizing 
    activities and accomplishments of the project.
        Send all reports to: David Elswick, Grants Management Specialist, 
    Grants Management Branch, Procurement and Grants Office, Centers for 
    Disease Control and Prevention (CDC), Room 300, 255 East Paces Ferry 
    Road, NE., Mailstop E-13, Atlanta, GA 30305-2209.
        The grantee will visit CDC, NIP at least twice a year for a verbal 
    progress report on all project activities.
        The following additional requirements are applicable to this 
    program.
    
    AR98-11  Healthy People 2000
    AR98-12  Lobbying Restrictions
    AR98-7  Executive Order 12372 Review
    AR98-8  Public Health System Reporting Requirements
    
    I. Authority and Catalog of Federal Domestic Assistance Number
    
        This program is authorized under the Public Health Service Act, 
    Section 317(k)(1)[42 U.S.C. 247b(k)(1)], as amended. The Catalog of 
    Federal Domestic Assistance number is 93.185.
    
    J. Where to Obtain Additional Information
    
        Please refer to Program Announcement 98063 when you request 
    information. For a complete program description, information on 
    application procedures, an application package, and business management 
    assistance, contact: David Elswick, Grants Management Specialist, 
    Grants Management Branch, Procurement and Grants Office, Announcement 
    98063, Centers for Disease Control and Prevention (CDC), Room 300, 255 
    East Paces Ferry Road, NE., Mailstop E-13, Atlanta, GA 30305-2209, 
    telephone (404) 842-6521, Email address DCE1@cdc.gov.
        See also the CDC home page on the Internet: http://www.cdc.gov
        For program technical assistance, contact Gary L. Euler, DrPH, 
    Chief, Hepatitis Activity, Adult Vaccine Preventable Diseases Branch, 
    Epidemiology and Surveillance Division, National Immunization Program, 
    Centers for Disease Control and Prevention (CDC), 1600 Clifton Road, 
    NE., Mailstop E-61, Atlanta, GA 30333, telephone (404) 639-8742, 
    Internet address: [email protected]
        To receive additional written information and to request an 
    application kit, call 1-888-GRANTS4 (1-888 472-6874). You will be asked 
    to leave your name and address and will be instructed to identify the 
    Announcement number of interest.
    
        Dated: May 28, 1998.
    Joseph R. Carter,
    Acting Associate Director for Management and Operations, Centers for 
    Disease Control and Prevention.
    [FR Doc. 98-14658 Filed 6-2-98; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
06/03/1998
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
98-14658
Pages:
30231-30233 (3 pages)
Docket Numbers:
Program Announcement 98063
PDF File:
98-14658.pdf